FDA Approved: AZURETTE — Supplemental Application (Mayne Pharma Inc.)

View source ↗

Summary

FDA granted a supplemental approval for Azurette, updating its labeling for the desogestrel/ethinyl estradiol combination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• AZURETTE (Desogestrel/ethinyl estradiol and ethinyl estradiol)

Snippet

SUPPL AP for AZURETTE (DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL)